Skip to main content

Search from vocabulary

Content language

Concept information

Preferred term

Ipilimumab  

Type

  • Topical Descriptor

Entry terms

  • Anti CTLA 4 MAb Ipilimumab
  • Anti-CTLA-4 MAb Ipilimumab
  • Ipilimumab, Anti-CTLA-4 MAb

Scope note

  • An anti-CTLA-4 ANTIGEN monoclonal antibody initially indicated for the treatment of certain types of metastatic MELANOMA. Its mode of actions may include blocking of CTLA-4 mediated inhibition of CYTOTOXIC T LYMPHOCYTES, allowing for more efficient destruction of target tumor cells.

History note

  • 2018(2012)

In other languages

URI

http://www.yso.fi/onto/mesh/D000074324

Download this concept:

RDF/XML TURTLE JSON-LD Created 7/11/17, last modified 2/28/20